The Relative Strength (RS) Rating for Aflac moved up into a higher percentile Tuesday, as it got a lift from 64 to 73.
IBD's unique rating identifies price action with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the trailing 52 weeks compares to all the other stocks in our database.
Over 100 years of market history reveals that the stocks that go on to make the biggest gains often have an RS Rating north of 80 in the early stages of their moves. See if Aflac can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
Aflac is working on a flat base with a 115.50 buy point. See if it can clear the breakout price in volume at least 40% above average.
Earnings grew 25% last quarter, up from 17% in the prior report. Revenue also increased, from -40% to 43%.
The company holds the No. 2 rank among its peers in the Insurance-Accident & Healthcare industry group. Unum Group is the top-ranked stock within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
